These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Is rifabutin prophylaxis against Mycobacterium avium complex infection in HIV infection worthwhile? The net impact on patients suggests not. Stephenson JM; Williams IG Genitourin Med; 1996 Aug; 72(4):272-6. PubMed ID: 8976833 [No Abstract] [Full Text] [Related]
23. Rifabutin prophylaxis against Mycobacterium avium complex infection. Zbrozek AS N Engl J Med; 1994 Feb; 330(6):437; author reply 438. PubMed ID: 7904329 [No Abstract] [Full Text] [Related]
24. Against the proposition: all patients with advanced HIV disease should be offered rifabutin prophylaxis. Pozniak A; Nelson MR Genitourin Med; 1996 Aug; 72(4):269-71. PubMed ID: 8976832 [No Abstract] [Full Text] [Related]
25. Rifabutin for MAC questioned. Posit Aware; 1995; ():6. PubMed ID: 11362571 [TBL] [Abstract][Full Text] [Related]
26. Hypopyon uveitis in patients with acquired immunodeficiency syndrome treated for systemic Mycobacterium avium complex infection with rifabutin. Saran BR; Maguire AM; Nichols C; Frank I; Hertle RW; Brucker AJ; Goldman S; Brown M; Van Uitert B Arch Ophthalmol; 1994 Sep; 112(9):1159-65. PubMed ID: 8085960 [TBL] [Abstract][Full Text] [Related]
27. Rifabutin use in inflammatory bowel disease. To KW; Tsiaras WG; Thayer WR Arch Ophthalmol; 1995 Nov; 113(11):1354. PubMed ID: 7487583 [No Abstract] [Full Text] [Related]
28. Uveitis associated with rifabutin therapy. Gioulekas J; Hall A Aust N Z J Ophthalmol; 1995 Nov; 23(4):319-21. PubMed ID: 11980079 [TBL] [Abstract][Full Text] [Related]
33. Recent development in the treatment and prevention of disseminated Mycobacterium avium complex (MAC). Schouten JT; Whittemore S STEP Perspect; 1996; 8(3):5-6. PubMed ID: 11364267 [TBL] [Abstract][Full Text] [Related]
34. [Uveitis with hypopyon in patients with acquired immunodeficiency syndrome, treated with Rifabutin]. Frau E; Gregoire-Cassoux N; Hannouche D; Lautier-Frau M; Vittecoq D; Offret H J Fr Ophtalmol; 1995; 18(6-7):435-8. PubMed ID: 7560784 [TBL] [Abstract][Full Text] [Related]
36. Lack of rifabutin resistance with prophylaxis for disseminated Mycobacterium avium complex. Böttger EC; Wallace RJ Lancet; 1994 Nov; 344(8935):1506-7. PubMed ID: 7734014 [No Abstract] [Full Text] [Related]
37. Mycobacterium avium intracellulare infection in patients with HIV or AIDS. Brettle RP J Antimicrob Chemother; 1997 Aug; 40(2):156-60. PubMed ID: 9301979 [No Abstract] [Full Text] [Related]
38. Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex disease in patients infected with the human immunodeficiency virus. Public Health Service Task Force on Prophylaxis and Therapy for Mycobacterium avium Complex. Masur H N Engl J Med; 1993 Sep; 329(12):898-904. PubMed ID: 8395019 [No Abstract] [Full Text] [Related]
39. Clinical and bacteriologic impact of rifabutin prophylaxis for Mycobacterium avium complex infection in patients with human immunodeficiency virus infection. Maslo C; Buré-Rossier A; Girard PM; Gholizadeh Y; Lebrette MG; Rozenbaum W Clin Infect Dis; 1997 Mar; 24(3):344-9. PubMed ID: 9114183 [TBL] [Abstract][Full Text] [Related]
40. Pattern of utilization of rifabutin for prophylaxis of Mycobacterium avium complex among patients with advanced human immunodeficiency virus disease in a community setting. Mandigo K; Hogg RS; Phillips P; Barber C; Le T; Bessuille E; Black W; O'Shaughnessy MV; Schechter MT; Montaner JS Tuber Lung Dis; 1996 Jun; 77(3):233-8. PubMed ID: 8758106 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]